Is there an influence of a genital prolapse and a compromised immune system on the development of a vaginal cancer? A data-analysis and review of literature

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021660

Enrollment

Registered

2020-05-05

Start date

2020-04-27

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaginal cancer C52

Interventions

Group 1: Patients with vaginal cancer and genital descensus. Systematic literature Research on the association of vaginal cancer and genital descensus in the scientific literature according to the PRI

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with vaginal cancer and genital descensus

Exclusion criteria

Exclusion criteria: Vagina metastasis from another primary

Design outcomes

Primary

Measure	Time frame
Statistical description of a coincidence of genital descensus and vaginal cancer	—

Secondary

Measure	Time frame
Capture other risk factors such as pre-surgery and immunosuppression	—

Countries

Germany

Contacts

Public ContactHeidrun Männle

Ortenau-Klinikum Offenburg-Kehl

heidrun.maennle@ortenau-klinikum.de0781/472-3501

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026